Manufacturer profile
Proteomedix AG
United Kingdom·Switzerland·3 products·1 device typesProfile overview
- Total Products
- 3
- Generic Names
- 2
- Device Types
- 1
- Generic Names
- 2
Manufacturer details
- Address
- Wagistrasse 23Schlieren, Switzerland
Device type portfolio
Products organized by device type
In Vitro Diagnostic Device3 products
Cancer risk assessment interpretive software IVD
Device ID: 175897 · DREGIY
Multiple solid tumour differentiation marker IVD, kit, enzyme immunoassay (EIA)
Device ID: 175898 · DREGIY
Multiple solid tumour differentiation marker IVD, kit, enzyme immunoassay (EIA)
Device ID: 150728
Recent registrations (3 most recent)
Most recently registered products with MHRA
Cancer risk assessment interpretive software IVDDec 17, 2023
Type: In Vitro Diagnostic Device
Device ID: 175897
Multiple solid tumour differentiation marker IVD, kit, enzyme immunoassay (EIA)Dec 17, 2023
Type: In Vitro Diagnostic Device
Device ID: 175898
Multiple solid tumour differentiation marker IVD, kit, enzyme immunoassay (EIA)Jul 1, 2022
Type: In Vitro Diagnostic Device
Device ID: 150728
About this profile
Proteomedix AG from Switzerland is a medical device manufacturer with 3 registered products in the UK MHRA database through Pure Global AI's free platform. The company produces 2 unique generic names across 1 device type.
This page provides comprehensive manufacturer intelligence including complete product portfolio and device type distribution. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.
Free Manufacturer ProfilePowered by Pure Global AI3 Products1 Types